An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
J
Jared Brosch, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to evaluate the long-term safety of the study drug nelotanserin and to assess the effects of nelotanserin in subjects experiencing frequent visual hallucination and/or REM sleep behavior disorders due to dementia with Lewy bodies.
Description
The purpose of this study is to evaluate the long-term safety of the study drug nelotanserin and to assess the effects of nelotanserin in subjects experiencing frequent visual hallucination and/or REM sleep behavior disorders due to dementia with Lewy bodies.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
dementia with Lewy bodies
-
Age: - 100 Years
-
Gender: All
Updated on
19 Apr 2024.
Study ID: 1610800176
